TY - JOUR
T1 - Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature
AU - Ikeguchi, Ryotaro
AU - Shimizu, Yuko
AU - Suzuki, Shigeaki
AU - Shimizu, Satoru
AU - Kabasawa, Chiaki
AU - Hashimoto, Shiori
AU - Masuda, Masayuki
AU - Nagane, Yuriko
AU - Utsugisawa, Kimiaki
AU - Suzuki, Yasushi
AU - Takahashi, Toshiyuki
AU - Utsumi, Hiroya
AU - Fujihara, Kazuo
AU - Suzuki, Norihiro
AU - Uchiyama, Shinichiro
N1 - Funding Information:
This work was supported in part by the Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan .
PY - 2014/10
Y1 - 2014/10
N2 - Background The incidence of concurrent myasthenia gravis (MG) and neuromyelitis optica spectrum disorder (NMOSD) is higher than what chance predicts, yet it remains unclear why MG and NMOSD appear concurrently. Objective The purpose of the present study was to examine the clinical features of the concurrence of these diseases. Methods Clinical details were analyzed retrospectively. Results Three (0.5%) out of 631 MG patients had confirmed (n = 2) or suspected (n = 1) NMOSD. Two of these patients were women. All showed early-onset MG (EOMG) that preceded NMOSD and were positive for acetylcholine receptor antibody (AChR-Ab). Two patients were tested for aquaporin 4 antibody (AQP4-Ab) and were positive. Two patients were treated with a thymectomy that preceded NMOSD. Two patients had decreased frequency of regulatory T (Treg) cells. We identified in the literature 46 patients with both MG and NMOSD. Our results of female predominance, EOMG, MG preceding NMOSD, and positive AChR-Ab are consistent with previous descriptions. Conclusions This is the first report to examine the frequency of NMOSD in Japanese patients with MG. The reduction and/or dysfunction of Treg cells may be one cause of NMOSD development in MG.
AB - Background The incidence of concurrent myasthenia gravis (MG) and neuromyelitis optica spectrum disorder (NMOSD) is higher than what chance predicts, yet it remains unclear why MG and NMOSD appear concurrently. Objective The purpose of the present study was to examine the clinical features of the concurrence of these diseases. Methods Clinical details were analyzed retrospectively. Results Three (0.5%) out of 631 MG patients had confirmed (n = 2) or suspected (n = 1) NMOSD. Two of these patients were women. All showed early-onset MG (EOMG) that preceded NMOSD and were positive for acetylcholine receptor antibody (AChR-Ab). Two patients were tested for aquaporin 4 antibody (AQP4-Ab) and were positive. Two patients were treated with a thymectomy that preceded NMOSD. Two patients had decreased frequency of regulatory T (Treg) cells. We identified in the literature 46 patients with both MG and NMOSD. Our results of female predominance, EOMG, MG preceding NMOSD, and positive AChR-Ab are consistent with previous descriptions. Conclusions This is the first report to examine the frequency of NMOSD in Japanese patients with MG. The reduction and/or dysfunction of Treg cells may be one cause of NMOSD development in MG.
KW - Acetylcholine receptor antibody
KW - Myasthenia gravis
KW - Neuromyelitis optica
KW - Regulatory T cell
KW - Thymectomy
UR - http://www.scopus.com/inward/record.url?scp=84906859526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906859526&partnerID=8YFLogxK
U2 - 10.1016/j.clineuro.2014.07.036
DO - 10.1016/j.clineuro.2014.07.036
M3 - Article
AN - SCOPUS:84906859526
SN - 0303-8467
VL - 125
SP - 217
EP - 221
JO - Clinical Neurology and Neurosurgery
JF - Clinical Neurology and Neurosurgery
ER -